Institut Mérieux
Institut Mérieux is a global leader in industrial microbiology, contributing to medicine and public health through diagnostics, immunotherapy, food safety, and nutrition.
Launch date
Employees
Lyon Auvergne-Rhône-Alpes (HQ)
Corporate Venture Fund: Mérieux Equity Partners, M2care
Financials
Estimates*
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Revenues | 9.4m | 10.4m | 11.2m | 10.5m | 13.8m |
| % growth | - | 11 % | 9 % | (6 %) | 31 % |
| EBITDA | (4.6m) | (3.6m) | (7.4m) | (7.7m) | (8.9m) |
| % EBITDA margin | (49 %) | (35 %) | (66 %) | (73 %) | (65 %) |
| Profit | 16.9m | 18.2m | 14.8m | 12.1m | (138m) |
| % profit margin | 180 % | 176 % | 132 % | 115 % | (998 %) |
Source: Dealroom estimates
